Author: Jane Edwards|| Date Published: February 28, 2022
The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for the proposed acquisition of health information technology company Cerner (Nasdaq: CERN) by Oracle (NYSE: ORCL) expired Tuesday, Feb. 22.
Oracle agreed to acquire Cerner for approximately $28.3 billion through an all-cash tender offer in late December and both parties expect the tender offer to expire on March 16, Oracle said Wednesday.
The tender offer of $95 a share for Cerner stock was originally scheduled to expire on Feb. 15, but Oracle announced on Feb. 11 that it extended the offer’s expiration by a month.
The two companies may further extend the tender offer to provide more time to satisfy the remaining conditions, including clearances under foreign direct investment laws and foreign competition laws.
Quantum computing company IonQ has entered into a definitive agreement to acquire SkyWater Technology, a U.S.-based pure-play semiconductor foundry, in a cash-and-stock transaction valued…
The Department of Veterans Affairs has started soliciting proposals for a potential 10-year, $700 billion multiple-award contract to provide Community…
Accenture Federal Services has appointed Garrett Berntsen, a federal and industry technical leader, as chief artificial intelligence officer. The latest…
